# LifeScan and Sanvita Medical partner to market CGM devices

LifeScan has entered into an exclusive agreement with Sanvita Medical to market continuous glucose monitoring (CGM) sensors. The companies plan to launch CGM systems in North America and select European countries as early as mid-2020.

- Type: Partnership
- Announced: 2019-05-21
- Where: United States
- Status: announced
- Products: continuous glucose monitoring sensors
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [LifeScan](https://endata.com/companies/30790.md)
- [Sanvita Medical](https://endata.com/companies/39508.md) (partner)

## Sources

- [prnewswire.com](https://www.prnewswire.com/news-releases/lifescan-enters-into-agreement-with-sanvita-medical-to-market-and-distribute-continuous-glucose-monitoring-cgm-devices-300853566.html), 2019-05-21: "There is a huge unmet need in diabetes management, and as a world leader in diabetes care we are excited to collaborate with Sanvita to help patients address that need with CGM technologies designed specifically with their concerns and goals in mind."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.